Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study

BACKGROUND: A high prevalence of antiphospholipid antibodies has been reported in case series of patients with neurological manifestations and COVID-19; however, the pathogenicity of antiphospholipid antibodies in COVID-19 neurology remains unclear. METHODS: This single-centre cross-sectional study...

Descripción completa

Detalles Bibliográficos
Autores principales: Benjamin, Laura A., Paterson, Ross W., Moll, Rachel, Pericleous, Charis, Brown, Rachel, Mehta, Puja R., Athauda, Dilan, Ziff, Oliver J., Heaney, Judith, Checkley, Anna M., Houlihan, Catherine F., Chou, Michael, Heslegrave, Amanda J., Chandratheva, Arvind, Michael, Benedict D., Blennow, Kaj, Vivekanandam, Vinojini, Foulkes, Alexander, Mummery, Catherine J., Lunn, Michael P., Keddie, Stephen, Spyer, Moira J., Mckinnon, Tom, Hart, Melanie, Carletti, Francesco, Jäger, Hans Rolf, Manji, Hadi, Zandi, Michael S., Werring, David J., Nastouli, Eleni, Simister, Robert, Solomon, Tom, Zetterberg, Henrik, Schott, Jonathan M., Cohen, Hannah, Efthymiou, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358233/
https://www.ncbi.nlm.nih.gov/pubmed/34401683
http://dx.doi.org/10.1016/j.eclinm.2021.101070

Ejemplares similares

Ejemplares similares